Upstream Bio, Inc.
UPB
$3.55-14.87%
End of day · as of Oct 13, 2026, 8:00 PM ET
Mkt cap
$407.33M
EV/Sales
107.1
P/E ratio
N/A
FY2025 Revenue
$2.85M
EPS (TTM)
$-2.88
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-5026.03%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
Use this UPB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full UPB income, balance, and cash tables.
Upstream Bio, Inc. (UPB) is a biotechnology company in the Healthcare sector.
Latest cached Upstream Bio, Inc. (UPB) revenue for Dec 31, 2025 was $2.9M. Net income was -$143.4M. Statements: https://lician.com/financials/upb
Upstream Bio, Inc. (UPB) market capitalization is $407.3M on the latest cached snapshot.
Upstream Bio, Inc. (UPB) cached previous close $4.17; day range $3.55 – $4.14; volume 1,037,222. Session quote: https://lician.com/quote/upb
Upstream Bio, Inc. (UPB) latest cached earnings event is "UPB earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached UPB filing is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/upb